What Pharma Misses About Drug/Device Products Is Wasting Time and Money

Drug/device combination products are transforming healthcare, but many pharma companies face hidden challenges that slow their progress. Misaligned priorities, complex regulatory requirements, and gaps in device-specific knowledge create costly delays and inefficiencies.

This session explores the three levels of harmonization critical for success: aligning global regulatory expectations, fostering effective collaboration between Sponsors and CMOs, and building synergy between internal pharma and device teams. Attendees will gain actionable strategies to navigate these hurdles, streamline development, and accelerate time-to-market without compromising quality or compliance. Equip your teams to tackle combination product complexities and drive faster, more successful launches.